Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Trump's crypto policies fuel sanction evasion and undermine US dollar dominance

Trump's crypto policies fuel sanction evasion and undermine US dollar dominance

ChaincatcherChaincatcher2026/04/21 02:40
Show original

According to ChainCatcher, Manchester University economics professor Jayati Ghosh pointed out in an article for the Bangkok Post that the Trump administration strongly promoted cryptocurrency deregulation and pushed for the GENIUS Act to promote USD-pegged stablecoins, while refusing to develop a central bank digital currency. However, this series of policies is having a self-destructive effect: in 2025, the volume of illegal cryptocurrency transactions increased by more than 160% year-on-year, with countries such as Russia, Iran, and North Korea using cryptocurrencies to massively evade US economic sanctions.

Among them, Iran has introduced cryptocurrencies into the Hormuz Strait transit fee collection system, with estimated daily revenues reaching as high as 36 million USD; Russia has bypassed asset freeze orders through crypto exchanges to fund military procurement.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss